GFC Life Science Co (XKRX:388610) EPS (Basic) : ₩ (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GFC Life Science Co EPS (Basic)?

GFC Life Science Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was ₩-1,872.00. GFC Life Science Co does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024.

GFC Life Science Co's EPS (Diluted) for the six months ended in Dec. 2024 was ₩-1,872.00. GFC Life Science Co does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024.

GFC Life Science Co's EPS without NRI for the six months ended in Dec. 2024 was ₩-410.16. GFC Life Science Co does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

GFC Life Science Co EPS (Basic) Historical Data

The historical data trend for GFC Life Science Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GFC Life Science Co EPS (Basic) Chart

GFC Life Science Co Annual Data

Trend

Dec23

Dec24

EPS (Basic)

685.00

-1,872.00

GFC Life Science Co Semi-Annual Data
	Dec23	Dec24
EPS (Basic)	685.00	-1,872.00

GFC Life Science Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

GFC Life Science Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5947.018	-	0)	/	3.177
	=	-1,871.90

GFC Life Science Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5947.018	-	0)	/	3.177
	=	-1,871.90

GFC Life Science Co (XKRX:388610) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

GFC Life Science Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of GFC Life Science Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

GFC Life Science Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GFC Life Science Co Ltd (XKRX:388610) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

823, Dongtansunhwan-daero, 17th Floor, Gyeonggi-do, Hwaseong-si, KOR

Website

http://www.gfcos.co.kr

GFC Life Science Co Ltd develops innovative cosmetics using a variety of sources. The company's ingredients specialize in human biotechnology, Bio-Phytochemistry, research of Bio-Fermentation, Unique Bio-Technology, anti-pollution material, and powder transfer technology.

GFC Life Science Co Headlines

No Headlines